Developer docs
API playgroundTry for free, no card

Search company profiles

TestCountry

Full company profile

uuid000v9el

Namestring
TestCountry
Legal namestring
Confirm Biosciences
Websiteurl
testcountry.com
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Confirm Biosciences (operating as the firmographic entity TestCountry) is a San Diego-based medical device and OTC diagnostics company founded in 2001. It designs and manufactures at-home rapid diagnostic tests across three categories: drugs of abuse (including fentanyl), infectious diseases (notably COVID-19/Flu A&B antigen), and women's health (pregnancy, UTI/pH, vaginal health screening). The company operates through sub-brands HealthConfirm and Drugconfirm, leveraging lateral flow immunoassay and rapid antigen detection chemistry manufactured under ISO 13485 and UL RCP certifications, with FDA 510(k) and de novo clearances.

The business model combines national branded product sales (through drugstores and mass/grocery), private label manufacturing for major retailers (including retailer-branded pregnancy and COVID/Flu tests), and direct enterprise/government sales to clinics, employers, and federal/state/local agencies. Pricing is quote-based through a B2B order portal and not publicly disclosed. Distribution spans 20,000+ retail locations through partnerships with Rite Aid, Walgreens, Walmart, CVS, H-E-B, and Bi-Mart. Value-added services — regulatory management and filings, supply chain warehousing/fulfillment, and enterprise training/certification — are positioned as strategic differentiators that extend beyond commodity manufacturing.

Operationally, the company runs a headcount of 11-50 employees from a single San Diego headquarters, holds a 20+ year operating history, and relies on major retail concentration as both its main commercial advantage and principal concentration risk. No revenue or funding figures are disclosed in available sources.

Short descriptiontext

Confirm Biosciences (TestCountry) is a San Diego-based OTC diagnostics manufacturer of at-home drug-of-abuse, infectious disease, and women's health tests, selling branded and private-label products through 20,000+ US retail locations and direct enterprise and government channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home diagnostic tests, lateral flow immunoassays, drug of abuse testing, private label diagnostics, rapid antigen test kits
Industry1 code
PRIMARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Packaging and Labeling Services56191
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Surgical & Medical Instruments & Apparatus3841
Product category
Diagnostic Medical Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1National Brand Product Sales
TypeHardware Sales
Description

Sale of branded OTC diagnostic products including pregnancy tests, COVID-19/Flu tests, UTI tests, and drug screening kits through retail partners

confirmbiosciences.com
2Private Label Manufacturing
TypeLicensing Royalties
Description

Custom manufacturing and private labeling of diagnostic products for major retail chains, including regulatory support and supply chain fulfillment

confirmbiosciences.com
3Enterprise Training & Certification
TypeProfessional Services
Description

Training and certification services for enterprise clients on diagnostic testing and compliance

confirmbiosciences.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1HealthConfirm
Description

Brand for health-related at-home test kits including UTI tests, pregnancy tests, and COVID-19/Flu tests

confirmbiosciences.com
+1 more record
Core offering1 text field

TestCountry (Confirm Biosciences) manufactures and distributes over-the-counter rapid diagnostic test kits, including drugs-of-abuse tests, infectious disease tests (COVID-19/Flu A&B antigen), and women's health tests (pregnancy, UTI/pH, and vaginal health screening). The company also offers end-to-end private label manufacturing, regulatory filing support, supply chain warehousing and fulfillment, and enterprise training and certification for retail and institutional clients across the United States.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Products available in 20,000+ retail locations nationwide
Product overview1 text field

Confirm Biosciences is a diagnostic and over-the-counter (OTC) testing products company offering a portfolio of branded and private-label products across three main categories: Drugs of Abuse Testing, Infectious Disease Tests (including COVID-19/Flu antigen tests), and Women's Health Tests (including pregnancy tests, UTI/pH kits, and vaginal health screening). The company provides end-to-end services including private label manufacturing, supply chain fulfillment, regulatory management and FDA filings, and enterprise training and certification. Products are available as national brands through retail partners and can be customized for private label clients.

Product and service11 records
1Drugs of Abuse Testing (point-of-care drug test kits)
2Infectious Disease Tests (COVID-19/Flu A&B antigen tests)
3Women's Health Tests (pregnancy, UTI/pH, vaginal health)
46 Days Sooner Pregnancy Test
5COVID-19/Flu A&B Antigen Test
6Urinary Tract Infection & pH At-Home Test Kit
7Vaginal Health Screening Kit
8Private Labeling Services
9Supply Chain Warehouse & Fulfillment
10Regulatory Management & Filings
11Enterprise Training & Certification
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major retail pharmacy chain distributing Confirm Biosciences branded diagnostic products through their retail locations nationwide.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

National pharmacy chain partner distributing OTC diagnostic products including drug tests, infectious disease tests, and women's health products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major retail partner for products including 6 Days Sooner Pregnancy Test, COVID-19/Flu Antigen Tests through Walmart retail and online channels.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

National pharmacy chain partner for OTC diagnostic product distribution through CVS retail locations.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional grocery retailer partner distributing diagnostic products in Texas and surrounding markets.

6Bi-Mart
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional retail chain partner distributing OTC diagnostic products in Pacific Northwest stores.

confirmbiosciences.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BTNX is a rapid diagnostic test manufacturer with comparable OTC product lines (drugs of abuse, infectious disease, women's health) sold through similar retail and workplace channels, making it a close functional and customer-overlap peer.

TypeDirect peer
Description

Premier Biotech focuses on drugs-of-abuse testing products for workplace, clinical, and at-home use, overlapping significantly with Confirm's Drugconfirm line and customer segments.

TypeEmerging player
Description

Mankind Pharma is expanding its at-home pregnancy and diagnostic test portfolio, representing an emerging competitor with comparable OTC product focus though primarily operating in a different geography (India) with growing US ambitions.

TypeBroad incumbent
Description

Church & Dwight owns the First Response pregnancy test brand, a direct competitor in Confirm's women's health category and a major OTC consumer-health incumbent with deep retail relationships across the same pharmacy chains.

TypeDirect peer
Description

Wondfo is a global OTC diagnostic manufacturer with overlapping product categories (pregnancy, drugs of abuse, infectious disease) using comparable lateral flow technology and similar retail/wholesale distribution models.

6Abbott Diagnostics
TypeBroad incumbent
Description

Abbott is a global diagnostics leader whose rapid test portfolio (Binax, ID NOW, and consumer products via Swiss Precision Diagnostics/Clearblue) competes in several of Confirm's categories at much larger scale and brand spend.

TypeDirect peer
Description

ACON Laboratories is a direct competitor producing Mission-brand OTC rapid diagnostic tests (drugs of abuse, pregnancy, infectious disease) with very similar product mix, FDA-cleared lateral flow technology, and global retail distribution — directly comparable in product, customer, and technology.

TypeDirect peer
Description

Princeton BioMeditech manufactures FDA-cleared rapid drug screening and infectious disease tests sold through workplace, clinical, and retail channels — a direct comparable in product category and target customer base.

TypeBroad incumbent
Description

Swiss Precision Diagnostics (jointly owned by P&G and Abbott) markets the Clearblue pregnancy and ovulation test brand, directly competing with Confirm's HealthConfirm pregnancy line on the same retailer shelves.

TypeBroad incumbent
Description

QuidelOrtho is a major IVD incumbent with a broad portfolio across rapid diagnostics (including Sofia and QuickVue brands) overlapping with Confirm's infectious disease and women's health categories, though at materially larger scale and broader clinical focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TestCountry

Diagnostic Medical Devicestestcountry.com

Confirm Biosciences (TestCountry) is a San Diego-based OTC diagnostics manufacturer of at-home drug-of-abuse, infectious disease, and women's health tests, selling branded and private-label products through 20,000+ US retail locations and direct enterprise and government channels.

What TestCountry does

Confirm Biosciences (operating as the firmographic entity TestCountry) is a San Diego-based medical device and OTC diagnostics company founded in 2001. It designs and manufactures at-home rapid diagnostic tests across three categories: drugs of abuse (including fentanyl), infectious diseases (notably COVID-19/Flu A&B antigen), and women's health (pregnancy, UTI/pH, vaginal health screening). The company operates through sub-brands HealthConfirm and Drugconfirm, leveraging lateral flow immunoassay and rapid antigen detection chemistry manufactured under ISO 13485 and UL RCP certifications, with FDA 510(k) and de novo clearances.

The business model combines national branded product sales (through drugstores and mass/grocery), private label manufacturing for major retailers (including retailer-branded pregnancy and COVID/Flu tests), and direct enterprise/government sales to clinics, employers, and federal/state/local agencies. Pricing is quote-based through a B2B order portal and not publicly disclosed. Distribution spans 20,000+ retail locations through partnerships with Rite Aid, Walgreens, Walmart, CVS, H-E-B, and Bi-Mart. Value-added services — regulatory management and filings, supply chain warehousing/fulfillment, and enterprise training/certification — are positioned as strategic differentiators that extend beyond commodity manufacturing.

Operationally, the company runs a headcount of 11-50 employees from a single San Diego headquarters, holds a 20+ year operating history, and relies on major retail concentration as both its main commercial advantage and principal concentration risk. No revenue or funding figures are disclosed in available sources.

TestCountry firmographics

Firmographics
Name
TestCountry
Legal name
Confirm Biosciences
Website
https://testcountry.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
Confirm Biosciences (TestCountry) is a San Diego-based OTC diagnostics manufacturer of at-home drug-of-abuse, infectious disease, and women's health tests, selling branded and private-label products through 20,000+ US retail locations and direct enterprise and government channels.
Ownership category
akta.pro rank

TestCountry industry classification

Industry
Product category
Diagnostic Medical Devices
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Packaging and Labeling Services (56191)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAIADAO
Home Diagnostic & Self-Test OTC Kits
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

  • At-home diagnostic tests
  • Lateral flow immunoassays
  • Drug of abuse testing
  • Private label diagnostics
  • Rapid antigen test kits

Where TestCountry is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

TestCountry business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. National Brand Product Sales: Sale of branded OTC diagnostic products including pregnancy tests, COVID-19/Flu tests, UTI tests, and drug screening kits through retail partners
  2. Private Label Manufacturing: Custom manufacturing and private labeling of diagnostic products for major retail chains, including regulatory support and supply chain fulfillment
  3. Enterprise Training & Certification: Training and certification services for enterprise clients on diagnostic testing and compliance

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

TestCountry product offering

Product offering

Core offering

TestCountry (Confirm Biosciences) manufactures and distributes over-the-counter rapid diagnostic test kits, including drugs-of-abuse tests, infectious disease tests (COVID-19/Flu A&B antigen), and women's health tests (pregnancy, UTI/pH, and vaginal health screening). The company also offers end-to-end private label manufacturing, regulatory filing support, supply chain warehousing and fulfillment, and enterprise training and certification for retail and institutional clients across the United States.

Product overview

Confirm Biosciences is a diagnostic and over-the-counter (OTC) testing products company offering a portfolio of branded and private-label products across three main categories: Drugs of Abuse Testing, Infectious Disease Tests (including COVID-19/Flu antigen tests), and Women's Health Tests (including pregnancy tests, UTI/pH kits, and vaginal health screening). The company provides end-to-end services including private label manufacturing, supply chain fulfillment, regulatory management and FDA filings, and enterprise training and certification. Products are available as national brands through retail partners and can be customized for private label clients.

Differentiator

Problem solved

Functional benefit

Brands

  • HealthConfirm: Brand for health-related at-home test kits including UTI tests, pregnancy tests, and COVID-19/Flu tests
  • Drugconfirm

Products and services

  • Drugs of Abuse Testing (point-of-care drug test kits)
  • Infectious Disease Tests (COVID-19/Flu A&B antigen tests)
  • Women's Health Tests (pregnancy, UTI/pH, vaginal health)
  • 6 Days Sooner Pregnancy Test
  • COVID-19/Flu A&B Antigen Test
  • Urinary Tract Infection & pH At-Home Test Kit
  • Vaginal Health Screening Kit
  • Private Labeling Services
  • Supply Chain Warehouse & Fulfillment
  • Regulatory Management & Filings
  • Enterprise Training & Certification

Quantifiable outcome

  • Products available in 20,000+ retail locations nationwide

Companies that use TestCountry

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles4 records

TestCountry technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

TestCountry partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Rite AidcoreChannel Partner/ Reseller/ DistributorMajor retail pharmacy chain distributing Confirm Biosciences branded diagnostic products through their retail locations nationwide.
  • WalgreenscoreChannel Partner/ Reseller/ DistributorNational pharmacy chain partner distributing OTC diagnostic products including drug tests, infectious disease tests, and women's health products.
  • WalmartcoreChannel Partner/ Reseller/ DistributorMajor retail partner for products including 6 Days Sooner Pregnancy Test, COVID-19/Flu Antigen Tests through Walmart retail and online channels.
  • CVS HealthcoreChannel Partner/ Reseller/ DistributorNational pharmacy chain partner for OTC diagnostic product distribution through CVS retail locations.
  • H-E-BcoreChannel Partner/ Reseller/ DistributorRegional grocery retailer partner distributing diagnostic products in Texas and surrounding markets.
  • Bi-MartminorChannel Partner/ Reseller/ DistributorRegional retail chain partner distributing OTC diagnostic products in Pacific Northwest stores.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

TestCountry competitors and assessment

Company assessment

Direct peers

  • BTNX Inc. BTNX is a rapid diagnostic test manufacturer with comparable OTC product lines (drugs of abuse, infectious disease, women's health) sold through similar retail and workplace channels, making it a close functional and customer-overlap peer.
  • Premier Biotech: Premier Biotech focuses on drugs-of-abuse testing products for workplace, clinical, and at-home use, overlapping significantly with Confirm's Drugconfirm line and customer segments.
  • Wondfo Biotech: Wondfo is a global OTC diagnostic manufacturer with overlapping product categories (pregnancy, drugs of abuse, infectious disease) using comparable lateral flow technology and similar retail/wholesale distribution models.
  • ACON Laboratories: ACON Laboratories is a direct competitor producing Mission-brand OTC rapid diagnostic tests (drugs of abuse, pregnancy, infectious disease) with very similar product mix, FDA-cleared lateral flow technology, and global retail distribution — directly comparable in product, customer, and technology.
  • Princeton BioMeditech Corporation: Princeton BioMeditech manufactures FDA-cleared rapid drug screening and infectious disease tests sold through workplace, clinical, and retail channels — a direct comparable in product category and target customer base.

Emerging players

  • Mankind Pharma: Mankind Pharma is expanding its at-home pregnancy and diagnostic test portfolio, representing an emerging competitor with comparable OTC product focus though primarily operating in a different geography (India) with growing US ambitions.

Broad incumbents

  • Church & Dwight (First Response): Church & Dwight owns the First Response pregnancy test brand, a direct competitor in Confirm's women's health category and a major OTC consumer-health incumbent with deep retail relationships across the same pharmacy chains.
  • Abbott Diagnostics: Abbott is a global diagnostics leader whose rapid test portfolio (Binax, ID NOW, and consumer products via Swiss Precision Diagnostics/Clearblue) competes in several of Confirm's categories at much larger scale and brand spend.
  • Swiss Precision Diagnostics (Clearblue): Swiss Precision Diagnostics (jointly owned by P&G and Abbott) markets the Clearblue pregnancy and ovulation test brand, directly competing with Confirm's HealthConfirm pregnancy line on the same retailer shelves.
  • QuidelOrtho: QuidelOrtho is a major IVD incumbent with a broad portfolio across rapid diagnostics (including Sofia and QuickVue brands) overlapping with Confirm's infectious disease and women's health categories, though at materially larger scale and broader clinical focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

TestCountry social profiles

Digital presence

TestCountry compliance and trust

Trust signal

Compliance3 records

TestCountry financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TestCountry leadership team

Management profile

Number of profiles

TestCountry funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TestCountry M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TestCountry

What does TestCountry do?

TestCountry (Confirm Biosciences) manufactures and distributes over-the-counter rapid diagnostic test kits, including drugs-of-abuse tests, infectious disease tests (COVID-19/Flu A&B antigen), and women's health tests (pregnancy, UTI/pH, and vaginal health screening). The company also offers end-to-end private label manufacturing, regulatory filing support, supply chain warehousing and fulfillment, and enterprise training and certification for retail and institutional clients across the United States.

Is TestCountry a public or private company?

TestCountry is a private company. It is classified as unknown and is currently operating.

When was TestCountry founded?

TestCountry was founded in 2001. It employs 11 to 50 people.

Where is TestCountry based?

TestCountry is headquartered in San Diego, United States, in the North America region.

How does TestCountry make money?

Three revenue lines are on record. National Brand Product Sales are the primary driver. The others are private Label Manufacturing and enterprise Training & Certification.

Who are TestCountry's main competitors?

Direct peers on record are BTNX Inc., Premier Biotech, Wondfo Biotech, ACON Laboratories and Princeton BioMeditech Corporation. Mankind Pharma is listed as an emerging player. Broad incumbents are Church & Dwight (First Response), Abbott Diagnostics, Swiss Precision Diagnostics (Clearblue) and QuidelOrtho.

Does TestCountry have an API?

No public API is recorded for TestCountry.

What industry is TestCountry in?

TestCountry's product category is Diagnostic Medical Devices. Its primary akta.pro industry code is HLAIADAO, Home Diagnostic & Self-Test OTC Kits. Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales